Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Nath Bio-Genes (India) Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,939	2,772	3,308	2,684	4,055	5,705
Market Cap Growth	-16.20%	-16.20%	23.22%	-33.79%	-28.93%	121.88%
Enterprise Value	4,275	4,026	4,283	3,836	4,810	6,296
Last Close Price	207.29	145.85	172.51	138.50	206.55	288.96
PE Ratio	10.44	7.18	8.35	7.67	-	10.25
PS Ratio	1.08	0.76	0.99	0.89	1.46	1.86
PB Ratio	0.61	0.43	0.54	0.47	0.75	0.93
P/TBV Ratio	0.62	0.44	0.55	0.48	0.77	0.95
P/FCF Ratio	40.78	28.69	6.92	7.57	-	-
P/OCF Ratio	22.41	15.77	4.43	7.00	23.78	512.63
EV/Sales Ratio	1.17	1.10	1.29	1.27	1.73	2.05
EV/EBITDA Ratio	8.59	8.09	8.57	7.85	12.78	9.38
EV/EBIT Ratio	9.30	8.76	9.16	8.36	13.92	9.79
EV/FCF Ratio	44.25	41.67	8.96	10.81	-	-
Debt / Equity Ratio	0.19	0.19	0.18	0.18	0.17	0.16
Debt / EBITDA Ratio	2.46	2.46	2.21	2.15	2.47	1.50
Debt / FCF Ratio	12.68	12.68	2.31	2.97	-	-
Asset Turnover	0.38	0.38	0.40	0.39	0.36	0.41
Inventory Turnover	0.48	0.48	0.38	0.38	0.42	0.46
Quick Ratio	0.50	0.50	0.68	0.66	0.50	0.84
Current Ratio	1.89	1.89	2.18	2.40	2.41	3.10
Return on Equity (ROE)	6.07%	6.07%	6.70%	6.28%	-11.67%	9.51%
Return on Assets (ROA)	3.02%	3.02%	3.49%	3.74%	2.83%	5.29%
Return on Capital (ROIC)	3.86%	3.86%	4.18%	4.37%	3.20%	5.99%
Return on Capital Employed (ROCE)	7.00%	7.00%	7.60%	8.00%	6.30%	10.40%
Earnings Yield	9.80%	13.93%	11.98%	13.04%	-16.62%	9.76%
FCF Yield	2.45%	3.49%	14.46%	13.22%	-0.98%	-1.83%
Dividend Yield	0.96%	1.37%	1.16%	1.44%	0.97%	0.69%
Payout Ratio	9.85%	9.85%	9.59%	10.86%	-	-
Buyback Yield / Dilution	-0.85%	-0.85%	-	-	-	-
Total Shareholder Return	0.12%	0.52%	1.16%	1.44%	0.97%	0.69%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.